Concepedia

Kuolung Hu

KH

Statistics

Publications

19

Citations

2K

H-Index

17

Active since

1998

Affiliations

Amgen (United States)(Current)

The University of Texas MD Anderson Cancer Center

Université Sorbonne Paris Nord

Cleveland Clinic

Heinrich Heine University Düsseldorf

Kuolung Hu is an author at Amgen (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1998–2021

19

Publications

19

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier et al. · Journal of Clinical Oncology · 2016 · 597 citations · Full text

The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes

Katherine R. Tuttle, George L. Bakris, Robert D. Toto et al. · Diabetes Care · 2005 · 301 citations · Full text

Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia

Hagop M. Kantarjian, Pierre Fenaux, Mikkael A. Sekeres et al. · Journal of Clinical Oncology · 2009 · 200 citations

Results of a randomized, double‐blind study of romiplostim versus placebo in patients with low/intermediate‐1–risk myelodysplastic syndrome and thrombocytopenia

Aristoteles Giagounidis, Ghulam J. Mufti, Pierre Fenaux et al. · Cancer · 2014 · 171 citations · Full text

Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy

Hagop M. Kantarjian, Francis J. Giles, Peter L. Greenberg et al. · Blood · 2010 · 150 citations · Full text

1–5 of 19